rPASA

Rapid Personalised Antibiotic Susceptibility Assay

Advantages

Rapid, Phenotypic, Low-cost/Affordable, Suitable for global markets.
Susceptibility testing directly from clinical samples.

Specifications

Technology:

Antimicrobial stewardship
Antimicrobial compound/strategy
Infection prevention
Microbial diagnostics
Removal antibiotics/bacteria

Microorganisms:

Bacteria
Viruses
Fungi
Yeasts
Parasites

Application:

Human
Veterinary
AgriFood
Environmental
Other

Development stage:

Development
Validation
Research
Market entry
Marketed product

Organization:

Institute
Company
Academia
NGO
Government

Partnering:

License
Co-develop
Joint Venture
Outsource
Sell

Funding organisation:

CARB-X
FIND
GARDP
REPAIR
OTHER / NA

Infectious disease area:

UTI
STI
BSI
RTI
GII
SSTI
CNSI
IAI
SSI

Geographic origin:

North America
South America
Eurasia
Africa
Oceania

Partnering

Looking for partners to co-develop/license.

Organisation

C-CAMP

Other

Modular platform technology based on compact microfluidics
Capabilities for multi-sampling and multiplexing
Tests micro volume samples for several antibiotics at the same time.

Address

Contact